Misdiagnosis of UTI in Women Technical Expert Panel
Signup Deadline: 2-12-2022
Through funding from the Gordon and Betty Moore Foundation, the American Institutes for Research (AIR) and the Infectious Diseases Society of America (IDSA) are developing a measure on the misdiagnosis of urinary tract infection (UTI) in women. Nearly half of all patients with asymptomatic bacteriuria (ASB) are misdiagnosed with UTI and are ultimately overprescribed antibiotics. Inappropriate treatment of misdiagnosed UTI is associated with greater risk of Clostridioides difficile infection (CDI), 90-day hospital readmission, and increased hospital length of stay. The goal of this effort is to reduce misdiagnosis of UTI by measuring the appropriate use of urinary culture testing only in the presence of UTI symptoms in accordance with evidence-based clinical practice guidelines. The primary desired outcome is to correctly diagnose ASB rather than UTI, and the secondary outcomes are to reduce antimicrobial overprescribing, antimicrobial resistance, and CDI. Please read the TEP Charter for additional details. To develop the measure, a technical expert panel (TEP) composed of clinical experts as well as patients, families and/or caregivers will be convened that represents a diversity of backgrounds, values, and perspectives. In addition to patient, family, and caregiver input, clinical expertise will be sought in the areas of infectious diseases, primary care, obstetrics-gynecology, and emergency medicine.
The responsibility of the TEP is to provide information, support, feedback, and perspective on the development, specification, and testing of clinical quality measures that reduce the misdiagnosis of asymptomatic bacteriuria as UTIs in women.
We are seeking individuals with differing perspectives and areas of expertise including:
- infectious diseases clinicians and other clinician experts involved in the diagnosis and treatment of women with UTIs, ASB and c. diff—including primary care providers, obstetrician-gynecologists and emergency medicine specialists
- patients, their family, and caregivers with lived experience of antimicrobial resistant infections, CDI, ASB or UTI
- individuals with experience in the development and implementation of quality measures that are meaningful to clinicians, patients, and caregivers alike;
- individuals with expertise in data science, artificial intelligence, and natural language processing (NLP); and
- individuals with expertise and experience in the areas of patient safety, quality improvement, and innovation.
Number of Members Needed:
The TEP will be composed of a Chair and 12 members.
6 quarterly meetings, starting in March 2022 and ending in June 2023. The TEP will meet by teleconference or videoconference quarterly for approximately 90 minutes. There will be approximately 1 hour of pre-work and 1-hour of post-work per scheduled meeting.
Expected Time Commitment:
The total time commitment of approximately 12 hours per year.
Method of Appointment:
Members are appointed by the IDSA Quality Improvement Committee in consultation with the American Institutes of Research (AIR)
Term of Office:
The TEP members will hold a minimum 18-month term with possible extension
The TEP is accountable to IDSA’s Quality Improvement Committee
Thomas Kim, IDSA Senior Program Officer
How to Apply
- Provide a completed TEP Nomination form.
- Provide a brief statement of interest (not to exceed 2 pages) highlighting your knowledge and/or lived experience relevant to the TEP and your involvement in measure development.
- Note: There is no expectation that patient/family/caregiver applicants have experience in measure development. These applicants can describe their interest in the topic.
- Provide a copy of your curriculum vitae (CV) or a summary of relevant experience (including publications) for a maximum of 10 pages.
- Note: There is no requirement for consumer/patient/family (caregiver) applicants/nominees to submit a CV.
- Submit your disclosures via the IDSA Conflict of Interest Form (PDF)
Send your TEP Nomination Form, CV/summary of relevant experience, and completed Conflict of Interest Form with “Nomination” in the subject line to MooreProject-AIR-IDSA@air.org. The documents are due by 5pm Eastern time on Saturday, February 12, 2022.